Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors

NCT02644369 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Cancer of Head and Neck
Triple Negative Breast Cancer
Epithelial Ovarian Cancer
Malignant Melanoma
Advanced Solid Tumors

Interventions

BIOLOGICAL: Pembrolizumab

Sponsor

University Health Network, Toronto

Collaborators

[object Object]